Jump to content

Search the Community

Showing results for tags 'vaccine'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Site Related
    • News & Updates
    • Site / Forum Feedback
    • Member Introduction
  • News
    • General News
    • FileSharing News
    • Mobile News
    • Software News
    • Security & Privacy News
    • Technology News
  • Downloads
    • nsane.down
  • General Discussions & Support
    • Filesharing Chat
    • Security & Privacy Center
    • Software Chat
    • Mobile Mania
    • Technology Talk
    • Entertainment Exchange
    • Guides & Tutorials
  • Off-Topic Chat
    • The Chat Bar
    • Jokes & Funny Stuff
    • Polling Station

Categories

  • Drivers
  • Filesharing
    • BitTorrent
    • eDonkey & Direct Connect (DC)
    • NewsReaders (Usenet)
    • Other P2P Clients & Tools
  • Internet
    • Download Managers & FTP Clients
    • Messengers
    • Web Browsers
    • Other Internet Tools
  • Multimedia
    • Codecs & Converters
    • Image Viewers & Editors
    • Media Players
    • Other Multimedia Software
  • Security
    • Anti-Malware
    • Firewalls
    • Other Security Tools
  • System
    • Benchmarking & System Info
    • Customization
    • Defrag Tools
    • Disc & Registry Cleaners
    • Management Suites
    • Other System Tools
  • Other Apps
    • Burning & Imaging
    • Document Viewers & Editors
    • File Managers & Archivers
    • Miscellaneous Applications
  • Linux Distributions

Categories

  • General News
  • File Sharing News
  • Mobile News
  • Software News
  • Security & Privacy News
  • Technology News

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

  1. Malaria vaccine hailed as potential breakthrough COPYRIGHTGETTY IMAGES A malaria vaccine has proved to be 77% effective in early trials and could be a major breakthrough against the disease, says the University of Oxford team behind it. Malaria kills more than 400,000 people a year, mostly children in sub-Saharan Africa. But despite many vaccines being trialled over the years, this is the first to meet the required target. The researchers say this vaccine could have a major public
  2. Pause of J&J vaccine was the right call, say 88% of polled Americans Poll results contradict concerns that the pause added to hesitancy. Enlarge / General exterior view of the head office of Janssen pharmaceutical company on April 15, 2021 in Leiden, Netherlands. About 88 percent of Americans support the pause of Johnson & Johnson’s COVID-19 vaccine, and the pause did not increase vaccine hesitancy, according to fresh data from the Axios-Ipsos Coronavirus poll. The finding is likely to hearten public health ex
  3. Facebook, Twitter reportedly partner with White House on vaccine push The social media giants are reportedly going to help get the word out about eligibility. Facebook and Twitter are reportedly going to help the White House get the word out about COVID-19 vaccine eligibility. Sarah Tew/CNET The White House has reportedly enlisted the aid of social media to promote information about vaccine eligibility. The Biden administration has partnered with Facebook and Twitter in a media blitz to promote President Joe Biden's new deadline for states to
  4. India's second wave hits the whole world through vaccine export curbs Facing a brutal new wave of coronavirus cases, India on Thursday made anyone over 45 eligible for vaccination. But the scramble to vaccinate as many people as possible has also meant sharply curtailing exports. Why it matters: The hopes of vaccinating the world have largely fallen on the shoulders of India, a vaccine manufacturing powerhouse and home to the world’s largest producer, the Serum Institute. Until recently, India was exporting most of the doses it was producing — a mix of donations
  5. Trial started for vaccine against one of the scariest coronavirus variants The vaccine is being developed "out of an abundance of caution," Fauci says. Enlarge / A vial of the current Moderna COVID-19 vaccine. Researchers have given out the first jabs of a tweaked version of Moderna’s COVID-19 vaccine, one aimed at fighting one of the most concerning coronavirus variants—the B.1.351 variant, first identified in South Africa. The jabs are part of an early trial of the tweaked vaccine, which is being run by the NIH’s National Institute of Allergy an
  6. Countries urge drug companies to share vaccine know-how A member of production checks cell growth and viability of a bioreactor sample under an inverted microscope inside the Incepta plant on the outskirts of Dhaka in Bangladesh Saturday Feb. 13, 2021. (AP Photo/Al-emrun Garjon) PARIS (AP) — In an industrial neighborhood on the outskirts of Bangladesh’s largest city lies a factory with gleaming new equipment imported from Germany, its immaculate hallways lined with hermetically sealed rooms. It is operating at just a quarter of its capacity. It is one
  7. Coronavirus: Latest data shows vaccine reduces transmission - Hancock There is "early data" showing a reduction in transmission in people who have had a coronavirus vaccine, the health secretary has said. Matt Hancock said hospital admissions were falling "much more sharply" than they were in the pandemic's first wave. The government aims to offer a first jab to all adults in the UK by the end of July, with one in three adults already vaccinated, Mr Hancock said. Boris John
  8. How long will the Pfizer and AstraZeneca vaccinations remain protective against COVID-19? The Federal Government plans to start distributing COVID-19 vaccines next week.(Getty Images: Sinology/Science Photo Library) Next week, the Pfizer vaccine rollout will begin and the first COVID-19 jab on Australian soil will take place. The Pfizer option will be given to priority groups (which includes quarantine workers and people living in aged care facilities) but most Australians will get the yet-to-be-approved Oxford-AstraZeneca jab. Health Minister Greg H
  9. Everyone should worry that Indians aren’t taking their second vaccine doses On Jan. 16, India started its vaccination drive against Covid-19, administering preliminary doses to nearly 200,000 healthcare workers, and reminding them to come back on Feb. 13 for their second shots. But when that date rolled around, fewer than 8,000 returned—a measly 4% of the total. By Monday morning (Feb. 15), the proportion had improved, but only just: 24,561 healthcare workers got their second shot out of the 224,301 who ought to have received it, or just over 10%.
  10. Scary 22% vaccine efficacy in South Africa comes with heaps of caveats South African data on AstraZeneca vaccine is as iffy as it is scary. Enlarge / Vials in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Dismal preliminary data on AstraZeneca’s COVID-19 vaccine in South Africa—where the B.1.351/ 501Y.V2 coronavirus variant is spreading widely—led the government there to rethink its vaccination rollout and raised further international concern about the variant. But th
  11. A Volunteer-Run Website Helps You Find a Vaccine Appointment in New York City's Online Maze A banner hangs from the ceiling at the Jacob K. Javits Convention Center on January 13, 2021 during a media tour of the new state vaccination site in New York City. Photo: Timothy A. Clary/AFP (Getty Images) It’s no secret that New York City, like many other places in the U.S., has been having a hard time with covid-19 vaccine distribution. One of the problems is its messy online sign-up website, which some city officials have denounced as “complex, burdensome, and buggy.
  12. Why you're seeing COVID-19 vaccine selfies all over Facebook and Twitter Misinformation on vaccines has run rampant on the internet, but some people are hoping vaccine selfies could help open a dialogue with skeptics. Jon Chapman isn't turning into a mutant. The 38-year-old medical laboratory scientist from Iowa City got his first COVID-19 vaccination the Monday before Christmas, and aside from a sore arm, he felt fine. Since then, he hasn't grown a tail, he doesn't have scales and -- so far -- there's no sign of wings. He wanted his friends and family to know thi
  13. Hey Google, where can I get vaccinated? — Google Maps will soon show COVID vaccine locations Vaccine site listings will show access requirements and appointment info. Enlarge / Vaccine info in Google search. Google The rollout of the COVID-19 vaccine means a ton of people are soon going to be looking for vaccination sites. As usual, Google wants to be at the center of getting people where they're going, and in a new blog post Google says it will start loading Search and Maps with information on vaccination
  14. Hackers using COVID vaccine as a lure to spread malware Criminals impersonating WHO, DHL, and vaccine manufacturers in phishing campaigns Security researchers have exposed a new phishing campaign that uses COVID-19 vaccine news to spread malware, phishing, and Business Email Compromise attacks (BEC). The attacks target individuals within businesses by impersonating organizations, including the WHO, DHL, and vaccine manufacturers. The themes leveraged a range of topics, including the fear that a person had encountered an infected individual; government
  15. There is no COVID vaccine reserve. Trump admin already shipped it "This is a deception on a national scale." Enlarge / Alex Azar, secretary of Health and Human Services (HHS), who allegedly deceived states on the vaccine supply, receives the Moderna COVID-19 vaccine during an event at the NIH Clinical Center on Tuesday, December 22, 2020. The Trump administration announced Tuesday, January 12, that it would begin shipping reserved vaccine supplies, raising hopes that states may see their vaccine supply potentially double as they work to accelerate the sluggis
  16. Nepal approves AstraZeneca COVID-19 vaccine for emergency use FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo KATHMANDU/NEW DELHI (Reuters) - Nepal on Friday granted approval for AstraZeneca’s COVISHIELD vaccine against the coronavirus, the government said, following a meeting with neighbouring India, a major manufacturer of the shot. “Conditional permission has been granted for e
  17. COVID-19: UK vaccinating 200,000 people a day - health minister FILE PHOTO: A man receives the Pfizer-BioNTech COVID-19 vaccine at a former nightclub that has been turned into a NHS vaccination centre for the coronavirus disease (COVID-19), at Batchwood Hall in St Albans, Britain, January 8, 2021. REUTERS/Paul Childs LONDON (Reuters) - Britain is vaccinating 200,00 people a day against COVID-19 and is on course to ramping up immunisations to 2 million a week, the rate needed to cover the most vulnerable by the middle of February, Health Secretary Matt Hancock said
  18. Researchers close in on 'universal' flu vaccine as COVID-19 fight takes priority Researchers may be one step closer to a universal flu vaccine, even as COVID-19 takes priority. File Photo by Roger L. Wollenberg/UPI | License Photo Jan. 8 (UPI) -- Researchers believe they are one step closer to a "universal" flu vaccine, even as concerns over the seasonal virus move to the back burner during the COVID-19 pandemic. T cells found in the lungs may hold the key to long-lasting immunity against influenza A, the more common and often more severe form of the v
  19. Hall of shame — “Shkreli Award” goes to Moderna for “blatantly greedy” COVID vaccine prices Moderna used $1 billion from feds to develop vaccine, then set some of the highest prices. Enlarge / COVID-vaccine-maker Moderna (right), has been placed in the ranks of Martin Shkreli (left). Drew Angerer / Florian Gaertner / Getty Images 147 with 97 posters participating One of the leading developers of COVID-19 vaccines has now been placed in the ranks of people like Martin Shkreli—the disgraced pharmaceutical ex
  20. Moderna says its COVID-19 vaccine is 94.5 percent effective in early analysis The company announced preliminary results on Monday Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images Moderna’s COVID-19 vaccine candidate is 94.5 percent effective, according to early data released by the company in a press release. That’s slightly higher than the efficacy reported by Pfizer and BioNTech; they announced a 90 percent efficacy for their vaccine candidate last week. Both Moderna and Pfizer said
  21. Key Points Uber shares rose 9% on Monday on optimism that a Covid-19 vaccine is on the way. Last week, the stock jumped 34%, as investors cheered the passage of California’s Proposition 22, which will allow Uber to keep classifying drivers as contractors. Revenue has been slumping and losses mounting, but the company says its margins are headed in the right direction. Investors are suddenly optimistic about Uber. Shares
  22. It’s going to take a lot longer to make a COVID-19 vaccine than a treatment Scientists have a head start on treatments Photo by Sylvain Lefevre / Getty Images Scientists and drug companies are racing to develop and test treatments and vaccines that address COVID-19, the disease caused by the novel coronavirus. Work on both is progressing at an unprecedented speed — but researchers are starting essentially from scratch on vaccine development, so the process is going to take a long time. Treatments, on the other hand,
  23. COVID-19 vaccine must protect 50% of people for approval, FDA says FDA sets rules for vaccine approval amid concern of hastiness and political pressure. Enlarge / Stephen Hahn, Commissioner of Food and Drugs at the US Food and Drug Administration (FDA), speaks during a Senate Health, Education, Labor and Pensions Committee hearing on June 30, 2020, in Washington, DC. Getty | Al Drago 59 with 49 posters participating Any experimental COVID-19 vaccines aspiring to earn regulatory approval from the Food and Drug Adm
  24. China moves forward with COVID-19 vaccine, approving it for use in military Early trial data suggests that vaccine is safe, but efficacy still unclear. Enlarge / Chinese President Xi Jinping learns about the progress on a COVID-19 vaccine during his visit to the Academy of Military Medical Sciences in Beijing on March 2, 2020. Getty | Xinhua News Agency 31 with 28 posters participating China has approved an experimental COVID-19 vaccine for use in its military after early clinical trial data suggested it was safe
  25. Everything You Need to Know About Coronavirus Vaccines As Covid-19 spreads, the pressure is on for drugmakers to get a vaccine to market. But it's not that easy. Since vaccine candidates started being developed in January, a version approved for public use won’t be available until the end of summer 2021, at the earliest. And that’s if nothing goes wrongPhotograph: Maria Toutoudaki/Getty Images It’s been fewer than three months since a novel coronavirus emerged
×
×
  • Create New...